Therapy Areas: Infectious Diseases
Biopharmaceutical company BioVaxys partner SpayVac for Wildlife scales up vaccine production in Madison facility
20 November 2024 - Biopharmaceutical company BioVaxys Technology Corp (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) and SpayVac for Wildlife Inc, a developer of humane fertility-control vaccines for animals, ...
Epigenic Therapeutics receives New Zealand approval for EPI-003 clinical trial
20 November 2024 - Epigenic Therapeutics, a Chinese biotechnology company developing next-generation gene modulation therapy, announced on Tuesday that it has received clinical trial application (CTA)...
TC BioPharm agrees research planning collaboration to develop Monkeypox treatment
23 October 2024 - TC BioPharm (Holdings) plc (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, announ...
GSK PLC announces acceptance of NDA for gepotidacin by US FDA
16 October 2024 - Biopharmaceutical company GSK PLC (LSE: GSK) (NYSE: GSK) announced on Wednesday that the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gepotid...
RedHill Biopharma's opaganib selected for Ebola treatment development by BARDA
14 October 2024 - Specialty biopharmaceutical company RedHill Biopharma Ltd. (Nasdaq:RDHL) announced on Monday that the Biomedical Advanced Research and Development Authority (BARDA) selected its drug...
Seegene finalises Werfen partnership agreement
9 October 2024 - Seegene Inc, a South Korean provider of solutions for PCR molecular diagnostics, announced on Tuesday that it has finalised a technology-sharing partnership agreement with Spanish dia...